Tenax Therapeutics (TENX) Revenue (2010 - 2015)

Tenax Therapeutics has disclosed Revenue across 5 years of filings, most recently posting $49286.0 for Q2 2015.

• Revenue for Q2 2015 came in at $49286.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2016 was $49286.0 (down 94.9% YoY), and the FY2015 annual result was $49286.0, changed N/A from the prior year.
• Revenue came in at $49286.0 for Q2 2015 at Tenax Therapeutics, down from $181572.0 in the prior quarter.
• In the past five years, Revenue ranged from a high of $514872.0 in Q4 2012 to a low of $24873.0 in Q3 2011.
• The 4-year median for Revenue is $95159.0 (2011), against an average of $151464.6.
• Across the five-year window, Revenue soared 993.94% in 2012 and soared 51.3% in 2013, its largest moves.
• Tenax Therapeutics' Revenue stood at $95159.0 in 2011, then jumped by 441.06% to $514872.0 in 2012, then slumped by 64.73% to $181572.0 in 2013, then sank by 72.86% to $49286.0 in 2015.
• The last three Revenue figures came in at $49286.0 (Q2 2015), $181572.0 (Q2 2013), and $221051.0 (Q1 2013), per Business Quant data.